配售代理已根据配售协议的条款及条件按配售价每股配售股份2.17港元成功配售合共2.76亿股配售股份 予不少于六名独立承配人，该等承配人全部为独立专业投资者、机构投资者及╱或其他个人投资者。据 董事所知、所悉及所信，于本公告日期，各承配人及其各自最终实益拥有人均独立于公司及其关连人 士。公司拟于2027年12月31日或之前将配售所得款项净额约5.97亿港元用作以下用途：(i)4.18亿港元(占 配售所得款项净额总额的70%)将用于开设科技体验店及拓展资产营运领域的新业务;及(ii)1.79亿港元(占 配售所得款项净额总额的30%)将用于一般企业营运资金用途，包括支付管理费用、业务扩展支出、偿 还到期债务等。 首程控股(00697)发布公告，配售协议的先决条件已获达成及配售完成已于2025年9月10日完成。 ...

Core Viewpoint - 嘉进投资国际 (00310.HK) has announced a conditional placement agreement to issue 500 million shares at a price of HKD 0.090 per share, which represents a discount of approximately 10.00% compared to the last trading price of HKD 0.100 on March 28, 2024 [1] Group 1 - The placement will be fully underwritten by the placement agent [1] - The total estimated proceeds from the placement are approximately HKD 45 million, with a net amount of about HKD 42 million after deducting commissions and other related expenses [1] - The net proceeds are intended for investment acquisitions, redemption of convertible bonds, and general working capital of the group [1]

Core Viewpoint - 嘉进投资国际 (00310) plans to issue 500 million shares, representing approximately 80.50% of the company's enlarged issued share capital after the placement [1] Summary by Relevant Sections - **Share Placement Details** - The placement price is set at HKD 0.090 per share, which is about a 10.00% discount compared to the closing price of HKD 0.100 on March 28, 2024 [1] - **Estimated Proceeds** - The total estimated gross proceeds from the placement are approximately HKD 45 million, with net proceeds estimated at HKD 42 million [1] - **Use of Proceeds** - The net proceeds of HKD 42 million are intended for investment acquisitions, redemption of convertible bonds, and general working capital of the group [1]

Core Viewpoint - Honghai High-Tech Resources (00065) announced a conditional placement agreement to issue up to 40.92 million shares at a price of HKD 0.40 per share, representing a discount of approximately 14.89% from the closing price of HKD 0.47 on September 5, 2025 [1] Summary by Relevant Sections - **Placement Details** - The company will place shares to no fewer than six independent third-party subscribers [1] - The placement shares represent about 16.67% of the enlarged issued share capital [1] - **Financial Implications** - If all 40.92 million shares are fully placed, the estimated gross proceeds will be approximately HKD 16.4 million, with net proceeds (after deducting placement commissions and other related expenses) estimated at about HKD 16.1 million [1] - **Use of Proceeds** - The net proceeds from the placement are intended for several potential investment opportunities identified in the mining industry and for general working capital of the group [1]

Group 1 - The core point of the article is that Shan Yu Group Holdings plans to issue up to 41.36 million new shares, representing approximately 16.67% of the enlarged total issued share capital after the placement [1] - The placement price is set at HKD 0.120 per share, which is about 11.11% lower than the closing price of HKD 0.135 on August 14 [1] - The net proceeds from the placement are estimated to be approximately HKD 4.91 million, intended for the company's operational funding [1] Group 2 - On September 3, a shareholder of Shan Yu Group Holdings deposited shares worth HKD 7.0312 million into Baoxin Securities, accounting for 20% of the total [1]

Group 1 - The company GBA Group plans to place a maximum of 46.5669 million shares, representing approximately 16.67% of the enlarged total share capital [1] - The placement price is set at HKD 0.200 per share, which is a discount of 12.66% compared to the closing price of HKD 0.229 on September 3 [1] - If the placement is fully completed, the expected net proceeds will be approximately HKD 8.61 million, which will be used for the company's general working capital and/or the development of new businesses [1]

Core Viewpoint - WuXi AppTec announced a placement agreement with an underwriter to fully underwrite up to 22.277 million shares at a price of HKD 58.85 per share, aiming to raise approximately HKD 1.311 billion in total, with net proceeds of about HKD 1.301 billion [1] Fund Utilization - Approximately 90% of the raised funds will be used to expand the company's service capabilities and production capacity, particularly in the areas of antibody-drug conjugates, active pharmaceutical ingredients, and clinical and commercial production [1] - The remaining approximately 10% of the funds will be allocated for the company's working capital and general corporate purposes [1]

Core Viewpoint - The company, Sihuan Pharmaceutical Holdings Group Ltd (02096), has entered into a placement and subscription agreement to issue 121 million shares at a price of HKD 12.95 per share, aiming to raise approximately HKD 1.567 billion for research and operational needs [1] Group 1 - The seller, Simcere Pharmaceutical Holding Limited, plans to sell 121 million shares through the placement agent at a price of HKD 12.95 per share [1] - The total estimated proceeds from the subscription are approximately HKD 1.567 billion, with a net amount of about HKD 1.5535 billion [1] - Approximately 90% of the proceeds will be allocated for research and development expenses, while around 10% will be used for working capital and other general corporate purposes [1]

Group 1 - The company, ZhongAn Group, announced a placement agreement to issue up to 48.3 million shares, representing approximately 9.3% of the total issued share capital of ZhongAn Technology as of the announcement date [1] - The placement price is set at HKD 3.53 per share, which is about 15.14% lower than the closing price of HKD 4.16 on the date of the agreement [1] - The net proceeds from the placement are estimated to be approximately HKD 168.5 million, intended to strengthen the future development of the company's core business, including investments in new industries and expanding market share [1] Group 2 - ZhongAn Technology is a company listed on the Hong Kong Stock Exchange and is a subsidiary of ZhongAn Group [1] - As of the announcement date, the company indirectly holds approximately 73.4% of the total issued shares of ZhongAn Technology [1] - Upon completion of the placement, assuming all 48.3 million shares are successfully placed, the company's indirect holding in ZhongAn Technology will decrease to approximately 64.1% [1]

假设所有配售股份获悉数配售，配售事项所得款项总额将约为4510万港元，而配售事项所得款项净额 (经扣除配售事项的配售佣金及其他开支后)将约为4400万港元。净价格约为每股配售股份0.576港元。公 司拟按以下方式动用所得款项净额：不少于70%用于扩展集团的产品销售业务;及余下用作集团一般营 运资金。 悟喜生活(08148)发布公告，于2025年8月29日(交易时段后)，公司与配售代理订立配售协议，据此，公 司已有条件同意透过配售代理按竭尽所能基准以每股配售股份0.59港元的配售价配售最多7635.84万股配 售股份予不少于6名承配人，而有关承配人与其最终实益拥有人将为独立第三方。每股配售股份0.59港 元的配售价较股份于最后交易日在联交所所报之收市价每股股份0.73港元折让约19.18%。 ...